EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Management of Intrahepatic Cholangiocarcinoma: A Narrative Review

Carolyn Tsung, Patrick L Quinn, Aslam Ejaz

Cancers · 10.02.2024 · 16 (4) · 739

DOI: 10.3390/cancers16040739 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.02.2024. Verfasst von Carolyn Tsung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of resectable intrahepatic cholangiocarcinoma remains a challenge due to the high risk of recurrence. Numerous clinical trials have identified effective systemic therapies for advanced biliary tract cancer; however, fewer trials have evaluated systemic therapies in the perioperative period. The objective of this review is to summarize the current recommendations regarding the diagnosis, surgical resection, and systemic therapy for anatomically resectable intrahepatic cholangiocarcinoma. Our review demonstrates that surgical resection with microscopic negative margins and lymphadenectomy remains the cornerstone of treatment. High-level evidence regarding specific systemic therapies for use in resectable intrahepatic cholangiocarcinoma remains sparse, as most of the evidence is extrapolated from trials involving heterogeneous tumor populations. Targeted therapies are an evolving practice for intrahepatic cholangiocarcinoma with most evidence coming from phase II trials. Future research is required to evaluate the use of neoadjuvant therapy for patients with resectable and borderline resectable disease.

Schlagwörter

Stichwörter der Autor:innen

adjuvantimmunotherapyintrahepatic cholangiocarcinomaprecision medicinesystemic therapytargeted therapy

Autor:innen und Institutionen

  • Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612, USA.

Förderung

  • AHRQ HHS

Zitieren

APA

Tsung, C., Quinn, P. L., & Ejaz, A. (2024). Management of Intrahepatic Cholangiocarcinoma: A Narrative Review. Cancers, 16(4), 739. https://doi.org/10.3390/cancers16040739

Vancouver

Tsung C, Quinn PL, Ejaz A. Management of Intrahepatic Cholangiocarcinoma: A Narrative Review. Cancers. 2024;16(4):739. doi:10.3390/cancers16040739

BibTeX
@article{Tsung2024,
  author = {Tsung, Carolyn and Quinn, Patrick L and Ejaz, Aslam},
  title = {Management of Intrahepatic Cholangiocarcinoma: A Narrative Review},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {739},
  doi = {10.3390/cancers16040739}
}
Kostenlos starten →